Extended-Release Niacin/Laropiprant Improves Overall Efficacy of Postprandial Reverse Cholesterol Transport
Author(s) -
Petra El Khoury,
Elisa Waldmann,
Thierry Huby,
Julie Gall,
Philippe Couvert,
JeanMarc Lacorte,
John Chapman,
Éric Frisdal,
Philippe Lesnik,
Klaus G. Parhofer,
Wilfried Le Goff,
Maryse Guérin
Publication year - 2015
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.115.306834
Subject(s) - postprandial , cholesterylester transfer protein , hypertriglyceridemia , medicine , niacin , reverse cholesterol transport , endocrinology , cholesterol , lipoprotein , chemistry , apolipoprotein b , triglyceride , pharmacology , insulin
Postprandial atherogenic lipoproteins, characterizing high-risk patients, correlate positively with cardiovascular events. Although the effect of niacin on fasting lipids is well established, its impact on atheroprotective reverse cholesterol transport (RCT) pathway and on functional features of circulating lipoproteins during the postprandial state remains indeterminate.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom